APA (7th ed.) Citation

DH, B., JS, H., GA, W., F, A., B, C., GL, S., . . . V, E. (2018). Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). European heart journal, 39(44), 3973. https://doi.org/10.1093/eurheartj/ehy413

Chicago Style (17th ed.) Citation

DH, Birnie, et al. "Continued Vs. Interrupted Direct Oral Anticoagulants at the Time of Device Surgery, in Patients with Moderate to High Risk of Arterial Thrombo-embolic Events (BRUISE CONTROL-2)." European Heart Journal 39, no. 44 (2018): 3973. https://doi.org/10.1093/eurheartj/ehy413.

MLA (9th ed.) Citation

DH, Birnie, et al. "Continued Vs. Interrupted Direct Oral Anticoagulants at the Time of Device Surgery, in Patients with Moderate to High Risk of Arterial Thrombo-embolic Events (BRUISE CONTROL-2)." European Heart Journal, vol. 39, no. 44, 2018, p. 3973, https://doi.org/10.1093/eurheartj/ehy413.